Deep Track Capital’s Beam Therapeutics BEAM Stock Holding History

Deep Track Capital’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34.3M	Buy	1,000,000 +179,235	+22%	+$5.41M	0.5%	46
2026 Q1	$19.6M	Buy	+820,765	New	+$22.8M	0.32%	53
2025 Q2	–	Sell	-315,765	Closed	-$6.17M	–	69
2025 Q1	$6.17M	Buy	+315,765	New	+$8.27M	0.2%	55
2023 Q4	–	Sell	-1,015,641	Closed	-$24.4M	–	64
2023 Q3	$24.4M	Sell	1,015,641 -301,675	-23%	-$8.09M	0.94%	31
2023 Q2	$42.1M	Buy	1,317,316 +67,316	+5%	+$2.18M	1.95%	18
2023 Q1	$38.3M	Buy	1,250,000 +83,527	+7%	+$3.3M	1.57%	24
2022 Q4	$45.6M	Buy	1,166,473 +166,473	+17%	+$7.46M	1.92%	20
2022 Q3	$47.6M	Sell	1,000,000 -250,000	-20%	-$14.3M	2.18%	14
2022 Q2	$48.4M	Buy	1,250,000 +486,250	+64%	+$19.3M	3.18%	12
2022 Q1	$43.8M	Buy	763,750 +63,750	+9%	+$4.18M	2.81%	13
2021 Q4	$55.8M	Buy	+700,000	New	+$59.9M	3.94%	7

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Deep Track Capital's BEAM Position: Q2 2026 in Review

Deep Track Capital increased its Beam Therapeutics (BEAM) stake by 22% in Q2 2026, buying an estimated $5.41M and bringing the position to 1,000,000 shares worth $34.3M. The position accounts for 0.5% of the portfolio, ranked #46.

Deep Track Capital first reported a position in BEAM in Q4 2021 and has held it in 11 quarters since. The position peaked at $55.8M in Q4 2021. 278 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

Deep Track Capital held 1,000,000 shares of Beam Therapeutics worth $34.3M as of Q2 2026.
Deep Track Capital bought 179,235 Beam Therapeutics shares in Q2 2026, an estimated $5.41M.
Beam Therapeutics made up 0.5% of Deep Track Capital's portfolio in Q2 2026, its #46 holding.
Deep Track Capital first reported a position in Beam Therapeutics in Q4 2021 and has held it in 11 quarters since.
Deep Track Capital's Beam Therapeutics position peaked at $55.8M in Q4 2021.
278 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Deep Track Capital's 13F filing for Q2 2026, filed 14 Aug 2026.